In a case-cohort study, 894 patients with DN were observed for approximately 8.7 years, showing that higher levels of plasma MCP-1 were related to DN progression.[54] In patients with DN, MCP-1 is an independent risk factor for ESRD and has important clinical value for evaluating DN prognosis. Here, CCL2 is linked to liver dysplastic nodule.